CINCLUS PHARMA
Cinclus Pharma is a research based biotech company developing small molecules for the treatment of gastric acid related diseases. Their main asset, X842, has been studied in a Phase I clinical trial. Cinclus Pharma is based in Basel, Switzerland.
CINCLUS PHARMA
Industry:
Biotechnology Clinical Trials Pharmaceutical
Founded:
2014-01-01
Address:
Mölndal, Vastra Gotaland, Sweden
Country:
Sweden
Website Url:
http://www.cincluspharma.com
Total Employee:
1+
Status:
Active
Total Funding:
490 M SEK
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Font Awesome Google Maps ReCAPTCHA Cloudflare JS CDN JS Typekit
Current Advisors List
Current Employees Featured
Founder
Investors List
Trill Impact
Trill Impact investment in Venture Round - Cinclus Pharma
Irrus Investments
Irrus Investments investment in Venture Round - Cinclus Pharma
EIR Ventures
EIR Ventures investment in Venture Round - Cinclus Pharma
Fjärde AP-fonden
Fjärde AP-fonden investment in Venture Round - Cinclus Pharma
Linc AB
Linc AB investment in Venture Round - Cinclus Pharma
Jonas Sjögren
Jonas Sjögren investment in Venture Round - Cinclus Pharma
Fourth Swedish National Pension Fund
Fourth Swedish National Pension Fund investment in Venture Round - Cinclus Pharma
Bengt Julander
Bengt Julander investment in Venture Round - Cinclus Pharma
Recipharm Venture Fund
Recipharm Venture Fund investment in Venture Round - Cinclus Pharma
Key Employee Changes
| Date | New article |
|---|---|
| 2021-02-25 | Cinclus Pharma Appoints Christer Ahlberg as Chief Executive Officer |
| 2020-04-16 | Cinclus Pharma Appoints Jenni Björnulfson as Chief Financial Officer |
Official Site Inspections
http://www.cincluspharma.com Semrush global rank: 6.17 M Semrush visits lastest month: 1.31 K
- Host name: 20.240.51.18
- IP address: 20.240.51.18
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cinclus Pharma"
On a Mission to Renew GERD Treatment | Cinclus Pharma
Cinclus Pharma is a Swedish clinical-stage pharma company developing small molecules for the treatment of gastric acid-related diseases. Our lead candidate linaprazan glurate is being …See details»
Management Team | Corporate Governance - Cinclus Pharma
Our management team at Cinclus Pharma, a Swedish pharma company developing linaprazan glurate, has a proven track record within drug discovery.See details»
Cinclus Pharma Appoints PSI as CRO for Its eGERD Phase III Program
E-mail: [email protected]. Charlotte Stjerngren, IR Phone: +46 70 876 87 87 e-mail: [email protected]. About linaprazan glurate. Linaprazan glurate …See details»
Cinclus Pharma - Crunchbase Company Profile & Funding
Cinclus Pharma is a research based biotech company developing small molecules for the treatment of gastric acid related diseases. Their main asset, X842, has been studied in a …See details»
appoints PSI as CRO for its eGERD phase III program
Jul 29, 2024 Cinclus Pharma ("the Company") announced today that Swiss-based global company PSI CRO will serve as the clinical research organization (CRO) for the phase III …See details»
Cinclus Pharma - Products, Competitors, Financials, Employees ...
Cinclus Pharma engages in clinical-stage pharmaceutical solutions focusing on developing small molecules for treating gastric acid-related diseases.See details»
CINCLUS PHARMA : S NOMINATION COMMITTEE FOR THE 2025 …
Nov 8, 2024 Cinclus Pharma Holding AB (publ) is a late-stage clinical pharmaceutical company developing drugs for the treatment of acid-related diseases and disorders of the upper …See details»
Cinclus Pharma Holding AB Company Description - Stock Analysis
Nov 29, 2024 Company profile for Cinclus Pharma Holding AB (publ) (STO: CINPHA) with a description, list of executives, contact details and other key facts.See details»
Cinclus Pharma Holding publ AB, CINPHA:STO profile - FT.com
Nov 12, 2024 Cinclus Pharma Holding AB (publ) (Cinclus Pharma) is a Sweden-based research based biotech company developing small molecules for the treatment of gastric acid related …See details»
Invitation to presentation of Cinclus Pharma’s third quarter report ...
Nov 4, 2024 e-mail: [email protected]. About Cinclus Pharma. Cinclus Pharma Holding AB (publ) is a late-stage clinical pharmaceutical company developing drugs …See details»
From Start-Up to Potential Global Game Changer | Cinclus Pharma
Cinclus Pharma was founded by pioneers in GERD treatment, both with extensive experience from Astra and AstraZeneca, where clinical Phase I and Phase II studies were performed on …See details»
Cinclus Pharma Holding AB: Cinclus Pharma has carried out a …
May 20, 2022 e-mail: [email protected]. About Cinclus Pharma and its lead candidate drug linaprazan glurate (former X842) Cinclus Pharma Holding AB is a clinical …See details»
Cinclus Pharma - Craft
See insights on Cinclus Pharma including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Cinclus Pharma : Invitation to presentation of Cinclus Pharma's …
Nov 4, 2024 Cinclus Pharma Holding AB (publ) is a late-stage clinical pharmaceutical company developing drugs for the treatment of acid-related diseases and disorders of the upper …See details»
Cinclus Pharma - Trill Impact
Cinclus Pharma is a Swedish late-stage biopharmaceutical company committed to improving the medical outcome for patients suffering from severe stomach acid-related disorders.See details»
Cinclus Pharma receives approval of the International …
Sep 6, 2021 Stockholm, Sweden: Cinclus Pharma Holding AB (“Cinclus Pharma”), a biopharmaceutical company focused on the development of a novel treatment for severe …See details»
News | Media | Cinclus Pharma
Nov 28, 2024 Latest company news from Cinclus Pharma, the Swedish pharma company developing effective treatments for gastric acid related diseases.See details»
Cinclus Pharma Company Information - Funding, Investors, and …
Track over 23,965 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 23,965 companies to help you find the right ones to partner with.See details»
Latest Press Releases and News | Cinclus Pharma
Nov 28, 2024 Find the latest news and press releases from the Swedish pharma company developing linaprazan glurate.See details»